Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Bachmann

Showing results (121-130 of 250) with videos related to

Pageof 25
Sort By:
Vaccines|November 27, 2021
Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 DiabetesAnne-Cathrine S Vogt, Elisa S Roesti, Mona O Mohsen, et al.
Biosensors & Bioelectronics|May 12, 2018
Biosensor-based selective detection of Zika virus specific antibodies in infected individualsGustavo Cabral-Miranda, Ana R Cardoso, Luis C S Ferreira, et al.
European Journal of Immunology|February 26, 2019
The thioredoxin-1 and glutathione/glutaredoxin-1 systems redundantly fuel murine B-cell development and responsesJonathan Muri, Helen Thut, Sebastian Heer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 4, 2023
BALB/c and C3H mice are both suitable as peanut allergy modelsPascal S Krenger, Jan Sobczak, Marta Paolucci, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2018
Vaccination against IL-31 for the treatment of atopic dermatitis in dogsMartin F Bachmann, Andris Zeltins, Gints Kalnins, et al.
European Journal of Immunology|February 14, 2007
Potent T cell agonism mediated by a very rapid TCR/pMHC interactionJonathan M Boulter, Nicole Schmitz, Andrew K Sewell, et al.
Plos One|September 10, 2008
Vaccination against GIP for the treatment of obesityAlma Fulurija, Thomas A Lutz, Katja Sladko, et al.
The Journal of Experimental Medicine|August 12, 2009
Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergyNicole Schmitz, Klaus Dietmeier, Monika Bauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Regulation of memory antibody levels: the role of persisting antigen versus plasma cell life spanDominique Gatto, Stephen W Martin, Juliana Bessa, et al.
Allergy|May 5, 2021
BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reducedXinyue Chang, Gilles Sousa Augusto, Xuelan Liu, et al.
Pageof 25

Showing results (121-130 of 250) with videos related to

Sort By:
Pageof 25
Vaccines|November 27, 2021
Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 DiabetesAnne-Cathrine S Vogt, Elisa S Roesti, Mona O Mohsen, et al.
Biosensors & Bioelectronics|May 12, 2018
Biosensor-based selective detection of Zika virus specific antibodies in infected individualsGustavo Cabral-Miranda, Ana R Cardoso, Luis C S Ferreira, et al.
European Journal of Immunology|February 26, 2019
The thioredoxin-1 and glutathione/glutaredoxin-1 systems redundantly fuel murine B-cell development and responsesJonathan Muri, Helen Thut, Sebastian Heer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 4, 2023
BALB/c and C3H mice are both suitable as peanut allergy modelsPascal S Krenger, Jan Sobczak, Marta Paolucci, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2018
Vaccination against IL-31 for the treatment of atopic dermatitis in dogsMartin F Bachmann, Andris Zeltins, Gints Kalnins, et al.
European Journal of Immunology|February 14, 2007
Potent T cell agonism mediated by a very rapid TCR/pMHC interactionJonathan M Boulter, Nicole Schmitz, Andrew K Sewell, et al.
Plos One|September 10, 2008
Vaccination against GIP for the treatment of obesityAlma Fulurija, Thomas A Lutz, Katja Sladko, et al.
The Journal of Experimental Medicine|August 12, 2009
Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergyNicole Schmitz, Klaus Dietmeier, Monika Bauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Regulation of memory antibody levels: the role of persisting antigen versus plasma cell life spanDominique Gatto, Stephen W Martin, Juliana Bessa, et al.
Allergy|May 5, 2021
BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reducedXinyue Chang, Gilles Sousa Augusto, Xuelan Liu, et al.
Pageof 25